Showing Results 1061 - 1070 of 1345
Out with the old and in with the new
A retrospective on Mesirow PrecisionAlpha ® vs the failure of traditional performance metrics, by Keith Gustafson CFA and Christopher M ONeill PhD CFA CFP, ®, FRM, ®, ChFC, ®, Executive summary This paper explores the impact of using trailing return to predict future performance The results may not be what many investors expect Our findings No truer phrase has been uttered than “past performance is no guarantee of future results” The most widely used metric of trailing return is a poor predictor of performance at both the one-year and three-year horizon The two broad…, ®, Mesirow’s answer to the shortcomings of traditional performance metrics is the most consistent predictor of performance across broad category sets for both one-year and three-year horizon periods in our study download
Outsourced trading
P&G brochure
P3 innovation
Mesirow acted as the exclusive underwriter of Health Services Facility Lease Revenue Bonds for The University of Illinois Hospital and Clinics in a Public-Private Partnership The Series 2020 Project consists of financing for the design and construction of a 200000 sf outpatient surgery and specialty clinic facility Delivery of the facilities by the private sector provides more immediate liquidity…, The UIC Surgery Center LLC, The University operates independent of the Hospital and therefore pledges a portion of its revenue for principal patient care services to secure the repayment of the Hospital’s debt Project delivery mechanism A pinnacle part of the unique “P3” structure is the mitigation of risk for taxpayers Through a delivery process like the one seen in Chart 1 the credit risk is essentially placed onto and…
Packaging
Packaging - Meet Our Team
Packaging Distribution Transactions
Packaging Perspectives 1Q2023 Market Update
Quarterly Highlights Share prices significantly underperformed the overall market Earnings declined double digits year over year and sequentialy primarily due to higher costs and lower volumes EBITDA margins remained relatively unchanged Valuations compressed further M&A activity declined significantly READ MORE